NASDAQ · Medical - Healthcare Information Services

GDRX (GDRX) Stock

$3.12 +2.30% NASDAQ: GDRX Healthcare

Valuation

MetricValue
Price$3.12
Market Cap$1.08B
P/E Ratio28.44
P/B Ratio1.44
P/S Ratio1.13
EPS (TTM)$0.09
52-Week High$5.81
52-Week Low$1.77
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE4.87%
ROA2.14%
ROCE14.12%
Gross Margin11.04%
Operating Margin10.92%
Net Margin2.61%
Debt/Equity0.09
Current Ratio2.61

Annual Financials (USD)

Metric20212022202320242025
Revenue$745.0M$767.0M$750.0M$792.0M$797.0M
Operating Profit$13.0M$2.0M$-27.0M$66.0M$87.0M
Net Profit$-25.0M$-33.0M$-9.0M$16.0M$30.0M
EPS$-0.06$-0.08$-0.02$0.04$0.09
Op Margin1.8%0.2%-3.6%8.3%11.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.6B$1.6B$1.6B$1.4B$1.4B
Total Liabilities$776.0M$790.0M$827.0M$663.0M$788.0M
Cash$941.0M$757.0M$672.0M$448.0M$262.0M
Borrowings$702.0M$717.0M$711.0M$543.0M$60.0M

Latest News

Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's StockStory · Jul 14, 2026 GoodRx (GDRX) Stock Trades Up, Here Is Why StockStory · Jul 13, 2026 GoodRx Holdings (GDRX) Pharma Growth Story Meets A Small Fair Value Gap Simply Wall St. · Jul 12, 2026 GoodRx (GDRX) Stock Looks Full On Earnings But Mixed On Value Simply Wall St. · Jul 11, 2026 GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call Business Wire · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$179.0M$147.0M$138.0M$184.0M$168.0M
Investing Cash Flow$-213.0M$-266.0M$-112.0M$-141.0M$-123.0M
Financing Cash Flow$-23.0M$-113.0M$-162.0M$-170.0M$-231.0M
Net Cash Flow$-30.0M$-184.0M$-85.0M$-224.0M$-187.0M
Free Cash Flow$144.0M$92.0M$83.0M$114.0M$164.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA3.98
FCF Yield14.83%
Quick Ratio1.47
Interest Coverage2.02
Return 1Y-43.06%
Return 3Y-56.65%
Return 5Y-89.95%

Ownership

Insiders Held12.78%
Institutions Held56.17%
Institutions Float Held64.39%
Institutional HolderSharesReport Date
Francisco Partners Management, LP60,078,1842026-03-31
LSV Asset Management4,981,9312026-03-31
Ameriprise Financial, Inc.4,455,7602026-03-31
Vanguard Capital Management LLC4,261,5162026-03-31
Silver Lake Group, LLC3,532,2762026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHCO $11.17 -0.45% 8.52 $1.52B 0.00%
AMPH $20.22 +1.40% 12.02 $891.56M 0.00%
COLL $35.58 +0.54% 17.33 $1.15B 0.00%
CTEVClaritev Corporation $21.73 +0.56% -1.25 $370.45M 0.00%
HSTM $28.72 +2.13% 37.21 $839.06M 0.56%

About GDRX

GDRX is led by CEO Wendy Barnes, employs 738 people, headquartered in US, publicly traded since 2020.

GDRX stock trades at $3.12 with a market capitalization of $1.08B. The stock is valued at a price-to-earnings (P/E) ratio of 28.44, price-to-book of 1.44, price-to-sales of 1.13. Over the past 52 weeks the stock has ranged between $1.77 and $5.81, and currently trades 46.3% below its 52-week high.

On profitability, GDRX generates a return on equity (ROE) of 4.87%, return on capital employed of 14.12%, an operating margin of 10.92%, a net profit margin of 2.61%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides